Claire Boniface, the marketing and communications manager at Ingood by Olga, spoke with us about the company’s latest Sulfodyne real-life clinical study, which she said underscores its advantages over traditional premenstrual syndrome (PMS) supplements like magnesium and chasteberry. She discussed exciting potential new applications for Sulfodyne in women’s health beyond PMS, including endometriosis and mood disorders, highlighting the company’s mission to address the diverse unmet needs within the women’s health category.
Upcoming webinars

Introducing LifeChews® and the Next Generation of Plant-based Supplements
Sirio

Why ARA & DHA matter: Key lipids shaping infant development
dsm-firmenich

Where Structure Drives Beauty: From Scalp Health to Skin Radiance
Monteloeder















